Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arsenic Trioxide for Relapsed or Refractory ALL
NCT00006008Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Jun 2000
- Modality
- DNA Intercalators/Alkylators
- Countries
- 3
01
Overview
A Phase 2 trial of arsenic trioxide in acute lymphoblastic leukemia (ALL), sponsored by Eastern Cooperative Oncology Group. Started Jun 2000; status: completed.
02
Drugs
arsenic trioxide
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00006008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006008.